DUSP9 and breast carcinoma: In previous studies, DUSP9 expression was downregulated in tumors and mediated the progression of CRC [17] and breast cancer [18] through the MAPK/ERK signaling pathway, which participated in HCC cell proliferation by regulating glucose metabolism and secretion of inflammatory factors [19].